| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Joel H Rubenstein | |
| Justin B Taylor | |||
| P2860 | cites work | The oesophagus lined with gastric mucous membrane | Q24515052 |
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Epidemiology and pathogenesis of esophageal cancer | Q28213313 | ||
| Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data | Q31919142 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy | Q82561091 | ||
| Development and validation of MIX: comprehensive free software for meta-analysis of causal research data | Q33260285 | ||
| Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia | Q33999961 | ||
| Prevalence of metaplasia at the gastro-oesophageal junction | Q34059892 | ||
| Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study | Q34099177 | ||
| Chronic peptic ulcer of the oesophagus and 'oesophagitis'. | Q34295930 | ||
| Prevalence of Barrett's esophagus in Korea | Q34412088 | ||
| Prevalence of Barrett's esophagus in the general population: an endoscopic study | Q34475247 | ||
| Clinical practice. Barrett's Esophagus | Q34563466 | ||
| Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. | Q34691502 | ||
| Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus | Q34761782 | ||
| Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study | Q34771871 | ||
| The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis | Q34786281 | ||
| Short segments of Barrett's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities? | Q35350847 | ||
| Symptomatic gastro-oesophageal reflux as a risk factor for oesophageal adenocarcinoma | Q35557662 | ||
| A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. | Q35827411 | ||
| Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux | Q39416473 | ||
| Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma | Q43758516 | ||
| Risk factors for Barrett's esophagus: a case-control study | Q43844084 | ||
| Prevalence of Barrett's esophagus in asymptomatic individuals | Q44081495 | ||
| Screening for Barrett's esophagus in colonoscopy patients with and without heartburn | Q44184935 | ||
| Intestinal metaplasia at the esophagogastric junction. Prevelence and association in patients undergoing endoscopy | Q44549509 | ||
| Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms | Q44846105 | ||
| Features of symptomatic gastroesophageal reflux disease in elderly patients | Q44980994 | ||
| Barrett's esophagus and medications that relax the lower esophageal sphincter | Q46043706 | ||
| Prevalence and clinical characteristics of Barrett's esophagus in a Chinese general population. | Q46687417 | ||
| Gastroesophageal reflux among different racial groups in the United States | Q46890169 | ||
| Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms | Q49186689 | ||
| Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study | Q50535523 | ||
| Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. | Q50661717 | ||
| The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus | Q50980340 | ||
| Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. | Q51824604 | ||
| Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. | Q54643270 | ||
| Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma | Q58204833 | ||
| Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer | Q63431426 | ||
| Barrett's esophagus in patients with symptomatic reflux esophagitis | Q69402120 | ||
| Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux | Q73002528 | ||
| Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms | Q73442183 | ||
| Risk factors for Barrett's oesophagus: a population-based approach | Q79844207 | ||
| Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all | Q79975061 | ||
| Abdominal obesity and body mass index as risk factors for Barrett's esophagus | Q80611327 | ||
| Prevalence of precancerous and other metaplasia in the distal oesophagus and gastro-oesophageal junction | Q81222355 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Barrett's esophagus | Q808892 |
| meta-analysis | Q815382 | ||
| P304 | page(s) | 1729, 1730-7; quiz 1738 | |
| P577 | publication date | 2010-05-18 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus | |
| P478 | volume | 105 |
| Q35637029 | A Multiscale Model Evaluates Screening for Neoplasia in Barrett's Esophagus |
| Q37114501 | A clinical risk prediction model for Barrett esophagus. |
| Q35759506 | A substantial incidence of silent short segment endoscopically suspected esophageal metaplasia in an adult Japanese primary care practice |
| Q40365358 | ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus |
| Q43728022 | Application of a multi-gene next-generation sequencing panel to a non-invasive oesophageal cell-sampling device to diagnose dysplastic Barrett's oesophagus |
| Q37557505 | Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus |
| Q38328606 | Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma |
| Q27332349 | BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia |
| Q95488201 | Barrett oesophagus |
| Q33959620 | Barrett's esophagus and cancer risk: how research advances can impact clinical practice |
| Q64121949 | Barrett's esophagus: novel strategies for screening and surveillance |
| Q41191034 | Barrett's oesophagus: Current controversies |
| Q34047978 | Barrett's oesophagus: Evidence from the current meta-analyses. |
| Q38608994 | Barrett's oesophagus: how should we manage it? |
| Q34380645 | British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus |
| Q98726725 | Chemoprevention of esophageal adenocarcinoma |
| Q38121501 | Colon cleansing for colonoscopy 2013: current status |
| Q38662491 | Columnar lined Barrett's oesophagus |
| Q61799774 | Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples |
| Q38005810 | Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process |
| Q30619561 | Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus |
| Q38919955 | Diabetes-induced mechanophysiological changes in the esophagus. |
| Q39571777 | Diagnosis and Management of Barrett's Esophagus: A Retrospective Study Comparing the Endoscopic Assessment of Early Esophageal Lesions in the Community versus a Specialized Center |
| Q26825742 | Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma |
| Q34132822 | Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video) |
| Q49979665 | Influence of hiatal hernia and male sex on the relationship between alcohol intake and occurrence of Barrett's esophagus. |
| Q54889608 | Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink. |
| Q30786254 | Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare Data |
| Q39101083 | Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia |
| Q38462853 | Novel surgical options for gastroesophageal reflux disease |
| Q46087987 | Optimization and expansion of predictive models for Barrett's esophagus and esophageal adenocarcinoma: could a life-course exposure history be beneficial? |
| Q33361584 | Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium |
| Q47901698 | Polymorphisms of the FOXF1 and MHC locus genes in individuals undergoing esophageal acid reflux assessments |
| Q37519245 | Prediction of Barrett's esophagus among men. |
| Q39502671 | Prevalence and Predictors of Gastroesophageal Reflux Complications in Community Subjects |
| Q50057605 | Recent Advances in Screening for Barrett's Esophagus. |
| Q37215328 | Research advances in esophageal diseases: bench to bedside |
| Q40879184 | Risk factors for Barrett's esophagus |
| Q38723616 | Risk factors for Barrett's esophagus: a scoping review |
| Q64079648 | Screening for Barrett's Esophagus: Balancing Clinical Value and Cost-effectiveness |
| Q34624586 | Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions |
| Q35815874 | The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma |
| Q90365251 | The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 |
| Q89972992 | Validation and Comparison of Tools for Selecting Individuals to Screen for Barrett's Esophagus and Early Neoplasia |
Search more.